{"id":"W2512557155","doi":"10.1016/s1474-4422(16)30192-2","title":"Safety and efficacy of amiselimod in relapsing multiple sclerosis (MOMENTUM): a randomised, double-blind, placebo-controlled phase 2 trial","year":2016,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"Mitsubishi Tanabe Pharma Corporation","keywords":"Medicine; Multiple sclerosis; Placebo; Clinical endpoint; Internal medicine; Population; Clinical trial; Randomized controlled trial; Interferon beta-1a; Immunology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001969002,0.0002307758,0.001523013,0.0002079363,0.0001152434,0.00001181611,0.0002266573,0.0001253359,0.00007055595],"category_scores_gemma":[0.003102245,0.0001183159,0.0001651539,0.0002154699,0.0005077317,0.00006303044,0.0001941529,0.0003829598,0.0000105226],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003565889,"about_ca_system_score_gemma":0.00006409786,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005973081,"about_ca_topic_score_gemma":0.00007239545,"domain_scores_codex":[0.9972032,0.0007082252,0.000732819,0.0004274648,0.0003292403,0.0005990984],"domain_scores_gemma":[0.9934862,0.005507085,0.0002468784,0.0005591853,0.00008064471,0.0001200396],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9286311,0.0004880182,0.001572788,0.00003013883,0.0001999744,0.00001410666,0.0002983201,0.00001022925,0.05784916,0.00003926398,0.0002513112,0.0106156],"study_design_scores_gemma":[0.9863307,0.0019269,0.00857909,0.0001172537,0.0001132648,0.00001106825,0.00001719201,0.0006206352,0.001313906,0.00002422821,0.0008394507,0.0001063249],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9767554,0.00042602,0.00008654215,0.01669462,0.0002164789,0.005150558,0.00002190702,0.00004636516,0.0006021037],"genre_scores_gemma":[0.9949985,0.003609819,0.00004567698,0.0003986906,0.0004227826,0.0003792456,0.000004054838,0.00002720362,0.0001140461],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0576996,"threshold_uncertainty_score":0.4824783,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1111109555709529,"score_gpt":0.3488235848093346,"score_spread":0.2377126292383817,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}